News / Events
Home/News/Events/News / Events/Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA

Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA

UPDATE : 2019/09/03
Virginia Contract Research Organization Co., Ltd.(VCRO) has successfully conducted and managed the clinical operation, data management, statistical analysis, medical writing, and GCP inspection of a phase I cell therapy IND-used study. In this clinical trial, VCRO has conquered diverse challenges the fast-paced nature of an cell therapy study, and overcame all the difficulties. On Sep-2019, the study was granted with an approval by TFDA for the GCP inspection. Just another epic VCRO milestone that we are excited to share with you!
舞狮争霸走势图 体彩黑龙江6十1中奖对照表 重庆时时彩后4组选6 sg飞艇平台推荐 李娜网球比分直播 麻将实战制胜百招 安徽手机麻将 上海十一选五直播 26选5今日开奖 幸运飞艇怎样看规律 四川时时彩 青海十一选五昨天开奖 10分11选5-正版APP下载 辽宁十一选五 蓝网球比分网 昆明按摩哪里便宜 北京快三开奖一定牛